Fetal Assessment and Abnormalities
Fetal assessment and abnormalities is the area of obstetrics concerned with evaluating the developing fetus and recognizing the conditions that disturb normal fetal growth, well-being, and survival. It brings together imaging, biophysical, and biochemical tools used to monitor the fetus across pregnancy and the spectrum of fetal disorders these tools are designed to detect.
Definition
Fetal assessment refers to the use of ultrasound biometry, Doppler velocimetry, amniotic fluid evaluation, and biophysical and biochemical testing to characterize fetal growth and well-being, while fetal abnormalities denote the structural, hematologic, growth, and outcome conditions that these assessments are intended to identify.
Scope
The area orients across the principal domains of antenatal fetal evaluation and the main categories of fetal abnormality: disorders of fetal growth, disturbances of amniotic fluid volume, fetal hydrops and hemolytic disease, the complications particular to multiple gestations, and intrauterine fetal demise. It frames these as reference topics within obstetrics rather than as a manual for clinical management.
Sub-topics
Core questions
- How is normal fetal growth distinguished from pathological growth restriction or excess?
- Which imaging and Doppler parameters best reflect fetal well-being and placental function?
- How are disturbances of amniotic fluid, fetal anemia, and hydrops recognized antenatally?
- What additional risks attend multiple gestations and how are they monitored?
Key concepts
- Fetal biometry and estimated fetal weight
- Doppler velocimetry (umbilical, middle cerebral, ductus venosus)
- Amniotic fluid assessment
- Fetal growth restriction
- Fetal anemia and hydrops
- Chorionicity and multiple gestation
- Antenatal surveillance and biophysical profile
Clinical relevance
The topics in this area underlie much of routine antenatal surveillance and the recognition of fetal compromise, and reading them critically supports appraisal of obstetric ultrasound and fetal-medicine evidence. The area describes how fetal conditions are characterized and is not a basis for individual diagnostic or management decisions.
Epidemiology
Fetal growth restriction, amniotic fluid abnormalities, hemolytic disease, multiple-gestation complications, and stillbirth together account for a substantial share of perinatal morbidity and mortality worldwide; their burden falls disproportionately on settings with limited access to antenatal imaging and surveillance (Lawn et al., 2016).
Evidence & guidelines
International bodies including ISUOG and ACOG publish standards for fetal biometry, growth assessment, and aneuploidy screening that structure contemporary fetal evaluation (Salomon et al., 2019; ACOG, 2020), while consensus definitions such as the Delphi criteria for fetal growth restriction aim to harmonize terminology across research and practice (Gordijn et al., 2016).
History
Antenatal fetal assessment expanded rapidly from the late twentieth century with the spread of real-time ultrasound, Doppler velocimetry, and, more recently, cell-free DNA screening, shifting fetal medicine from indirect inference toward direct visualization and physiological monitoring of the fetus.
Related topics
Seminal works
- gordijn-2016
- salomon-2019
Frequently asked questions
- What does fetal assessment involve?
- It involves ultrasound measurement of fetal size and anatomy, Doppler study of blood flow in fetal and placental vessels, evaluation of amniotic fluid, and biophysical or biochemical tests used to gauge fetal growth and well-being across pregnancy.
- How does this area relate to its individual topics?
- It is an orienting overview; the detailed essentials of growth restriction, amniotic fluid disorders, hydrops and hemolytic disease, multiple gestations, and fetal demise are covered in the topic entries nested beneath it.